MORGENS WATERFALL VINTIADIS & CO INC - REATA PHARMACEUTICALS INC ownership

REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 218 filers reported holding REATA PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 0.42 and the average weighting 0.9%.

Quarter-by-quarter ownership
MORGENS WATERFALL VINTIADIS & CO INC ownership history of REATA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2020$3,120,000
+260.3%
20,000
+233.3%
2.00%
+146.9%
Q1 2020$866,000
-89.0%
6,000
-84.5%
0.81%
-84.9%
Q4 2019$7,890,000
+158.6%
38,600
+1.6%
5.36%
+128.8%
Q3 2019$3,051,000
-5.9%
38,000
+10.6%
2.34%
+5.0%
Q2 2019$3,241,000
+18.5%
34,350
+7.3%
2.23%
+14.1%
Q1 2019$2,735,000
+52.4%
32,0000.0%1.96%
+22.5%
Q4 2018$1,795,000
-31.4%
32,0000.0%1.60%
-6.7%
Q3 2018$2,616,000
+87.0%
32,000
-20.0%
1.71%
+72.7%
Q2 2018$1,399,00040,0000.99%
Other shareholders
REATA PHARMACEUTICALS INC shareholders Q1 2020
NameSharesValueWeighting ↓
DekaBank Deutsche Girozentrale 17,000$2,9300.01%
PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO 93,711$1,6120.00%
IFP Advisors, Inc 300$51,7080.00%
View complete list of REATA PHARMACEUTICALS INC shareholders